Epilepsy – UCB EP0165

The purpose of the study is to evaluate the long-term safety and tolerability of Staccato alprazolam.

Inclusion criteria:

• Participant must be ≥12 years of age at the time of signing informed consent
• Participant must have a study caregiver ≥18 years of age at the time of signing the informed consent; the study caregiver(s) must be able to recognize and observe the participant’s seizures
• Participants with an established diagnosis of focal or generalized epilepsy or combined focal and generalized epilepsy with a documented history of stereotypical episodes of prolonged seizures that includes at least 1 of the following:

1. Generalized seizure episodes starting with a flurry of absence seizures or myoclonic seizures with a minimum total duration of 5 minutes
2. Episodes of a focal seizure with a minimum duration of 3 minutes
3. Episodes of a focal seizure or a flurry of myoclonic seizures for at least 90 seconds followed by a generalized/bilateral tonic-clonic seizure with a minimum total duration of 3 minutes

Complete the form to get connected and our team will reach out soon to help determine your eligibility.